Sunday - May 24, 2026
Bergman, Correa Lead Letter Urging FDA to Expedite Review of Breakthrough Mental Health Therapies
May 06, 2026
WASHINGTON, May 6 -- Rep. Jack Bergman, R-Michigan, issued the following news release:

* * *

Bergman, Correa Lead Letter Urging FDA to Expedite Review of Breakthrough Mental Health Therapies

*

Last week, Reps. Jack Bergman and Lou Correa, co-chairs of the Congressional Psychedelics Advancing Therapies Caucus, led 30 bipartisan colleagues in sending a letter to Food and Drug Administration (FDA) Commissioner Martin A. Makary urging the agency to . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products